Facioscapulohumeral Dystrophy

Prevalence

30.0 / 100K

1 drug in development·1 company·1 clinical trial

Drug Pipeline by Phase

Frequently asked questions

How many drugs are in development for Facioscapulohumeral Dystrophy?

BioSniper tracks 1 drug in development for Facioscapulohumeral Dystrophy across 1 company.

How many clinical trials target Facioscapulohumeral Dystrophy?

There are 1 clinical trial targeting Facioscapulohumeral Dystrophy tracked by BioSniper.

What is the prevalence of Facioscapulohumeral Dystrophy?

The estimated prevalence of Facioscapulohumeral Dystrophy is approximately 30.0 per 100,000 population.

Deep-dive into Facioscapulohumeral Dystrophy

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Facioscapulohumeral Dystrophy — Drugs in Development & Clinical Trials | BioSniper